Cargando…
Pharmacological models in Alzheimer's disease research
Wider use of pharmacological models would facilitate the development of new drugs for Alzheimer's disease (AD), The two main models currently used are based on the cholinergic and glutamatergic hypotheses of AD, Although they lead to some of the attention and memory impairment observed in AD, t...
Autores principales: | Gilles, Christian, Ertlé, Stéphane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Les Laboratoires Servier
2000
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181609/ https://www.ncbi.nlm.nih.gov/pubmed/22034060 |
Ejemplares similares
-
Treatment of cognitive impairment in Alzheimer's disease
por: Burns, Alistair
Publicado: (2003) -
Pharmacologic treatment of schizophrenia
por: Kane, John M., et al.
Publicado: (2010) -
The clinical pharmacology of depressive states
por: Schulz, Pierre, et al.
Publicado: (2002) -
Biological predictors of pharmacological therapy in anxiety disorders
por: Maron, Eduard, et al.
Publicado: (2015) -
A critical review of cholinesterase inhibitors as a treatment modality in Alzheimer's disease
por: S. Schneider, Lon
Publicado: (2000)